EDAPT Perfusion Practice Test

The therapeutic effect expected from the use of an aldosterone inhibitor like spironolactone primarily involves decreased fluid retention. Aldosterone plays a key role in regulating sodium and water balance in the body. When aldosterone levels are high, it promotes the reabsorption of sodium in the kidneys, which leads to water retention and increased blood volume. By inhibiting aldosterone, spironolactone reduces sodium reabsorption, leading to increased excretion of sodium and water, thus decreasing fluid retention. This mechanism is particularly beneficial in conditions such as heart failure and hypertension, where fluid overload is a significant issue.

While reduced blood pressure is often a consequence of decreased fluid retention, it is not the primary therapeutic target of aldosterone inhibitors compared to the direct effect on fluid balance. Increased heart rate and improved myocardial contractility are not effects associated with the use of spironolactone; instead, the medication focuses on fluid management rather than directly affecting heart rate or the strength of heart contractions. Therefore, the primary expected outcome of using spironolactone is indeed decreased fluid retention.